Listed

Coherus Oncology, Inc.

CHRSNasdaqCIK 1512762HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$14.3m, Q2 FY2026
Operating income−$32.3m, Q2 FY2026
Net income−$20.6m, Q2 FY2026
Coherus Oncology, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m74.6Revenue, Q3 FY2023, three months to 2023-09-30$74.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure91.5Revenue, Q4 FY2023, three months to 2023-12-31$91.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure2.3Revenue, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure10.3Revenue, Q2 FY2024, three months to 2024-06-30$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure6.1Revenue, Q3 FY2024, three months to 2024-09-30$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure7.7Revenue, Q4 FY2024, three months to 2024-12-31$7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure7.6Revenue, Q1 FY2025, three months to 2025-03-31$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure10.3Revenue, Q2 FY2025, three months to 2025-06-30$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure11.6Revenue, Q3 FY2025, three months to 2025-09-30$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure12.7Revenue, Q4 FY2025, three months to 2025-12-31$12.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure12.3Revenue, Q1 FY2026, three months to 2026-03-31$12.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure14.3Revenue, Q2 FY2026, three months to 2026-06-30$14.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Cost of revenue$m32.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$32.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure84.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$84.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure1.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure1.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure2.7Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure2.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure2.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure3.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure3.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure4.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure3.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure4.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m25.6Research and development, Q3 FY2023, three months to 2023-09-30$25.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure26.4Research and development, Q4 FY2023, three months to 2023-12-31$26.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure28.4Research and development, Q1 FY2024, three months to 2024-03-31$28.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure20.6Research and development, Q2 FY2024, three months to 2024-06-30$20.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure22.1Research and development, Q3 FY2024, three months to 2024-09-30$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure20.8Research and development, Q4 FY2024, three months to 2024-12-31$20.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure24.4Research and development, Q1 FY2025, three months to 2025-03-31$24.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure26.3Research and development, Q2 FY2025, three months to 2025-06-30$26.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure27.3Research and development, Q3 FY2025, three months to 2025-09-30$27.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure31.0Research and development, Q4 FY2025, three months to 2025-12-31$31.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure21.5Research and development, Q1 FY2026, three months to 2026-03-31$21.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure21.4Research and development, Q2 FY2026, three months to 2026-06-30$21.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Selling, general and administrative$m48.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$48.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure49.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$49.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure40.2Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$40.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure27.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$27.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure28.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$28.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure29.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$29.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure26.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$26.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure26.0Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$26.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure24.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$24.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure23.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$23.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure23.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$23.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure21.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$21.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Operating income$m(32.0)Operating income, Q3 FY2023, three months to 2023-09-30−$32.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure(68.9)Operating income, Q4 FY2023, three months to 2023-12-31−$68.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure(67.8)Operating income, Q1 FY2024, three months to 2024-03-31−$67.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure(39.6)Operating income, Q2 FY2024, three months to 2024-06-30−$39.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure(46.9)Operating income, Q3 FY2024, three months to 2024-09-30−$46.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(45.4)Operating income, Q4 FY2024, three months to 2024-12-31−$45.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(45.4)Operating income, Q1 FY2025, three months to 2025-03-31−$45.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(45.5)Operating income, Q2 FY2025, three months to 2025-06-30−$45.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(44.3)Operating income, Q3 FY2025, three months to 2025-09-30−$44.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(45.9)Operating income, Q4 FY2025, three months to 2025-12-31−$45.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(36.2)Operating income, Q1 FY2026, three months to 2026-03-31−$36.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(32.3)Operating income, Q2 FY2026, three months to 2026-06-30−$32.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Interest expense$m10.3Interest expense, Q3 FY2023, three months to 2023-09-30$10.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure10.6Interest expense, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure3.1Interest expense, Q1 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure4.1Interest expense, Q2 FY2024, three months to 2024-06-30$4.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure2.8Interest expense, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure1.9Interest expense, Q4 FY2024, three months to 2024-12-31$1.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure2.2Interest expense, Q1 FY2025, three months to 2025-03-31$2.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure2.3Interest expense, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure2.3Interest expense, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure2.2Interest expense, Q4 FY2025, three months to 2025-12-31$2.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure2.2Interest expense, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure2.3Interest expense, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Income tax$m(0.4)Income tax, Q3 FY2023, three months to 2023-09-30−$380.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(39.6)Net income, Q3 FY2023, three months to 2023-09-30−$39.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure(79.7)Net income, Q4 FY2023, three months to 2023-12-31−$79.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure103Net income, Q1 FY2024, three months to 2024-03-31$102.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(12.9)Net income, Q2 FY2024, three months to 2024-06-30−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(10.8)Net income, Q3 FY2024, three months to 2024-09-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(50.7)Net income, Q4 FY2024, three months to 2024-12-31−$50.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(56.6)Net income, Q1 FY2025, three months to 2025-03-31−$56.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure298Net income, Q2 FY2025, three months to 2025-06-30$297.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(35.5)Net income, Q3 FY2025, three months to 2025-09-30−$35.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(37.6)Net income, Q4 FY2025, three months to 2025-12-31−$37.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(38.3)Net income, Q1 FY2026, three months to 2026-03-31−$38.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(20.6)Net income, Q2 FY2026, three months to 2026-06-30−$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Diluted EPS$ per share(0.41)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figurenot reported0.91Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure(0.11)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure(0.09)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figurenot reported2.57Diluted EPS, Q1 FY2025, three months to 2025-03-31$2.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure2.57Diluted EPS, Q2 FY2025, three months to 2025-06-30$2.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(0.31)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(0.13)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Basic EPS$ per share(0.41)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figurenot reported0.91Basic EPS, Q1 FY2024, three months to 2024-03-31$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure(0.11)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure(0.09)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figurenot reported(0.49)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure2.57Basic EPS, Q2 FY2025, three months to 2025-06-30$2.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(0.31)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figurenot reported(0.28)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(0.13)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure

Balance sheet

Cash and equivalents$82.9m, Q2 FY2026
Shareholders' equity$60.8m, Q2 FY2026
Coherus Oncology, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m80.3Cash and equivalents, Q3 FY2023, at 2023-09-30$80.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure103Cash and equivalents, FY2023, at 2023-12-31$102.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0001558370-25-003126.Report this figure260Cash and equivalents, Q1 FY2024, at 2024-03-31$259.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure159Cash and equivalents, Q2 FY2024, at 2024-06-30$159.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure97.7Cash and equivalents, Q3 FY2024, at 2024-09-30$97.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure126Cash and equivalents, FY2024, at 2024-12-31$126.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure82.4Cash and equivalents, Q1 FY2025, at 2025-03-31$82.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure217Cash and equivalents, Q2 FY2025, at 2025-06-30$216.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure103Cash and equivalents, Q3 FY2025, at 2025-09-30$103.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure88.9Cash and equivalents, FY2025, at 2025-12-31$88.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure115Cash and equivalents, Q1 FY2026, at 2026-03-31$115.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure82.9Cash and equivalents, Q2 FY2026, at 2026-06-30$82.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Current assets$m444Current assets, Q3 FY2023, at 2023-09-30$444.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001558370-23-017779.Report this figure476Current assets, FY2023, at 2023-12-31$475.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001558370-25-003126.Report this figure627Current assets, Q1 FY2024, at 2024-03-31$627.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure558Current assets, Q2 FY2024, at 2024-06-30$557.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure369Current assets, Q3 FY2024, at 2024-09-30$369.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure342Current assets, FY2024, at 2024-12-31$341.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure310Current assets, Q1 FY2025, at 2025-03-31$310.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure380Current assets, Q2 FY2025, at 2025-06-30$380.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure461Current assets, Q3 FY2025, at 2025-09-30$461.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure207Current assets, FY2025, at 2025-12-31$206.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure206Current assets, Q1 FY2026, at 2026-03-31$206.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure134Current assets, Q2 FY2026, at 2026-06-30$133.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Total assets$m584Total assets, Q3 FY2023, at 2023-09-30$583.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001558370-23-017779.Report this figure630Total assets, FY2023, at 2023-12-31$629.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001558370-25-003126.Report this figure764Total assets, Q1 FY2024, at 2024-03-31$763.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure675Total assets, Q2 FY2024, at 2024-06-30$674.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure505Total assets, Q3 FY2024, at 2024-09-30$505.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure449Total assets, FY2024, at 2024-12-31$448.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure371Total assets, Q1 FY2025, at 2025-03-31$371.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure439Total assets, Q2 FY2025, at 2025-06-30$439.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure517Total assets, Q3 FY2025, at 2025-09-30$516.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure258Total assets, FY2025, at 2025-12-31$258.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure266Total assets, Q1 FY2026, at 2026-03-31$266.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure191Total assets, Q2 FY2026, at 2026-06-30$191.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Current liabilities$m240Current liabilities, Q3 FY2023, at 2023-09-30$239.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001558370-23-017779.Report this figure332Current liabilities, FY2023, at 2023-12-31$331.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0001558370-25-003126.Report this figure538Current liabilities, Q1 FY2024, at 2024-03-31$538.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure463Current liabilities, Q2 FY2024, at 2024-06-30$463.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure296Current liabilities, Q3 FY2024, at 2024-09-30$295.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure283Current liabilities, FY2024, at 2024-12-31$283.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure255Current liabilities, Q1 FY2025, at 2025-03-31$255.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure264Current liabilities, Q2 FY2025, at 2025-06-30$263.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure372Current liabilities, Q3 FY2025, at 2025-09-30$372.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure140Current liabilities, FY2025, at 2025-12-31$140.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure132Current liabilities, Q1 FY2026, at 2026-03-31$132.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure75.5Current liabilities, Q2 FY2026, at 2026-06-30$75.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Total liabilities$m717Total liabilities, Q3 FY2023, at 2023-09-30$717.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001558370-23-017779.Report this figure823Total liabilities, FY2023, at 2023-12-31$823.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0001558370-25-003126.Report this figure845Total liabilities, Q1 FY2024, at 2024-03-31$845.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure759Total liabilities, Q2 FY2024, at 2024-06-30$759.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure593Total liabilities, Q3 FY2024, at 2024-09-30$593.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure581Total liabilities, FY2024, at 2024-12-31$580.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure555Total liabilities, Q1 FY2025, at 2025-03-31$554.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure320Total liabilities, Q2 FY2025, at 2025-06-30$319.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure429Total liabilities, Q3 FY2025, at 2025-09-30$428.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure197Total liabilities, FY2025, at 2025-12-31$197.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure187Total liabilities, Q1 FY2026, at 2026-03-31$187.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure130Total liabilities, Q2 FY2026, at 2026-06-30$130.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(134)Shareholders' equity, Q3 FY2023, at 2023-09-30−$133.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure(193)Shareholders' equity, FY2023, at 2023-12-31−$193.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001104659-26-025308.Report this figure(81.8)Shareholders' equity, Q1 FY2024, at 2024-03-31−$81.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(84.1)Shareholders' equity, Q2 FY2024, at 2024-06-30−$84.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(88.0)Shareholders' equity, Q3 FY2024, at 2024-09-30−$88.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure(132)Shareholders' equity, FY2024, at 2024-12-31−$132.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure(183)Shareholders' equity, Q1 FY2025, at 2025-03-31−$183.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure120Shareholders' equity, Q2 FY2025, at 2025-06-30$119.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure87.8Shareholders' equity, Q3 FY2025, at 2025-09-30$87.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure61.0Shareholders' equity, FY2025, at 2025-12-31$61.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure78.6Shareholders' equity, Q1 FY2026, at 2026-03-31$78.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure60.8Shareholders' equity, Q2 FY2026, at 2026-06-30$60.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure

Cash flow

Operating cash flow−$62.1m, Q2 FY2026
Capital expenditure$34.0k, Q4 FY2023
Coherus Oncology, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(54.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$54.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001558370-24-014648. Derived: 9-month figure less the 6-month figure.Report this figure(12.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0001558370-25-003126. Derived: 12-month figure less the 9-month figure.Report this figure(46.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$46.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure59.7Operating cash flow, Q2 FY2024, three months to 2024-06-30$59.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001558370-25-010803. Derived: 6-month figure less the 3-month figure.Report this figure(62.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$62.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001104659-25-107852. Derived: 9-month figure less the 6-month figure.Report this figure28.6Operating cash flow, Q4 FY2024, three months to 2024-12-31$28.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(25.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(46.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$46.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091262. Derived: 6-month figure less the 3-month figure.Report this figure(46.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$46.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001104659-25-107852. Derived: 9-month figure less the 6-month figure.Report this figure(19.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001104659-26-025308. Derived: 12-month figure less the 9-month figure.Report this figure(57.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$57.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure(62.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$62.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091262. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-11-06, accession 0001558370-23-017779. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-15, accession 0001558370-24-003436. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)154.82m, Q2 FY2026
Coherus Oncology, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares77.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3077,746,895 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001558370-23-017779.Report this figure79.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3179,268,853 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001558370-24-007641.Report this figure87.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3087,269,614 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001558370-24-011629.Report this figure97.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3097,738,509 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001558370-24-014648.Report this figure113Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31112,749,306 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001558370-25-007418.Report this figure115Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30114,819,965 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001558370-25-010803.Report this figure115Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30115,210,091 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure116Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31116,077,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure116Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30116,077,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure116Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30116,229,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001104659-25-107852.Report this figure136Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31136,398,303 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001104659-26-058703.Report this figure155Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30154,816,912 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure

Shares outstanding: 154.50mShares outstanding, period not labelled, at 2026-07-31154,500,966 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091262.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.